Skip to content

Comparison of different Selective Laser Trabeculoplasty (SLT) protocols in the treatment of Open Angle Glaucoma and Ocular Hypertension

Performance of Selective Laser Trabeculoplasty (SLT) protocols - Enhanced and Transscleral - in the treatment of patients with Open Angle Glaucoma and Ocular Hypertension: randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4njj56p
Enrollment
Unknown
Registered
2025-10-06
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open Angle Glaucoma

Interventions

Randomized clinical trial comparing a conventional Selective Laser Trabeculoplasty (cSLT) protocol with an enhanced protocol (eSLT) and transscleral application (tSLT) in patients with open-angle glau
1.4 mJ in eyes with mild to moderate pigmentation). Regarding the application method, the application will be performed directly (transscleral) under the limbus.

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 40 yo; Both sexes; Clinical indication for bilateral SLT; Diagnosis of ocular; hypertension or open angle glaucoma (mild to moderate); Open angle on gonioscopy; Baseline intraocular pressure equal to or greater than 16 mmHg

Exclusion criteria

Exclusion criteria: Gonioscopy alterations; Previous intraocular surgery or laser; History of ocular trauma; Advanced OAG; Other types of glaucoma; Associated ophthalmological diseases; Unreliable data; Participants in other clinical trials

Design outcomes

Primary

MeasureTime frame
It is expected to observe reduction above 20% compared to the initial intraocular pressure measured by Goldmann applanation tonometer after treatment with SLT;It is expected to observe reduction of one or more medications compared to the initial therapy after SLT

Secondary

MeasureTime frame
Evaluate the occurence of adverse events in the postoperative period of SLT;Observe the presence of endothelial alterations in specular microscopy after SLT;Evaluate quality of life assessment associated to the treatment with SLT;Assessment of predictors of success to the treatment with SLT

Countries

Brazil

Contacts

Public ContactIsabela Valle

Universidade Federal de São Paulo

isabelavianello@gmail.com+55319979790270

Outcome results

None listed

Source: REBEC (via WHO ICTRP)